Biogen Inc. (ETR:IDP)
Germany · Delayed Price · Currency is EUR 152.30
+3.20 (2.15%)
Feb 2, 2026, 3:39 PM CET
Biogen Market Cap
Biogen has a market cap or net worth of €22.21 billion as of February 2, 2026. Its market cap has increased by 11.24% in one year.
Market Cap
22.21B
Enterprise Value
24.43B
Revenue
8.58B
Ranking
n/a
PE Ratio
16.20
Stock Price
€152.30
Market Cap Chart
Since September 17, 1991, Biogen's market cap has increased from 126.71M to 22.21B, an increase of 17,429.69%. That is a compound annual growth rate of 16.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 22.21B | 1.02% |
| Dec 31, 2025 | 21.99B | 2.16% |
| Dec 31, 2024 | 21.52B | -36.55% |
| Dec 29, 2023 | 33.92B | -9.09% |
| Dec 30, 2022 | 37.31B | 20.41% |
| Dec 31, 2021 | 30.99B | 0.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 54.72B |
| Siemens Healthineers AG | 46.92B |
| Bayer Aktiengesellschaft | 43.24B |
| Fresenius SE & Co. KGaA | 26.29B |
| Sartorius Aktiengesellschaft | 14.92B |
| Fresenius Medical Care AG | 10.38B |
| Fielmann Group AG | 3.45B |
| Carl Zeiss Meditec AG | 2.45B |